Medical Devices, Medications, and TSA: How to Navigate Security With Health Equipment in 2026

Traveling with a medical device or condition requires navigating a checkpoint environment designed for the average healthy traveler, using federal legal protections that many travelers do not know they have. The Air Carrier Access Act (ACAA) and its implementing regulation, 14 CFR Part 382, create a robust set of rights for passengers with disabilities and medical conditions that go well beyond the latitude most travelers assume they receive at the checkpoint. Understanding these protections before you travel transforms the security experience from an anxiety-generating uncertainty into a process you can navigate with confidence.

This guide covers the specific rules, procedures, and legal protections that apply at every stage of travel for passengers with CPAP machines, insulin-dependent conditions, cardiac implants, and other medical equipment. It also addresses a critically underappreciated risk: medications that are legal in the United States but constitute controlled substances in certain destination countries, where carrying them without the correct documentation can result in detention.

Your Legal Rights as a Traveler With a Medical Condition

The Air Carrier Access Act, codified at 49 U.S.C. § 41705 and implemented through 14 CFR Part 382, prohibits discrimination in air travel on the basis of disability. This framework applies to all U.S. carriers on all routes and to foreign carriers operating flights to or from the United States. It is enforced by the DOT's Office of Aviation Consumer Protection, which has demonstrated willingness to issue substantial penalties: the landmark $50 million penalty against American Airlines in October 2024 for widespread disability accommodation failures signals an era of active enforcement.

Under Part 382, airlines must accommodate medical needs at the checkpoint and during the flight without requiring passengers to pay additional fees for that accommodation. A CPAP machine is a medical device, not a personal item or carry-on bag; it cannot be counted against your carry-on allowance. A wheelchair is assistive equipment, not checked baggage; the airline is responsible for it in the same way it is responsible for not damaging the aircraft. Requests for medical assistance during boarding, including the use of an aisle chair, must be honored without penalty.

The TSA's Disability Notification Card provides a discreet mechanism for communicating medical conditions, implants, or devices to TSA officers at the checkpoint. The card is available for download from the TSA website. Presenting it before screening allows the officer to proceed with the appropriate alternative screening method without the passenger needing to explain a sensitive condition verbally in a crowded checkpoint environment. The card is not a screening waiver; it does not exempt the passenger from any required screening. It is a communication tool that makes the process more efficient and less intrusive.

CPAP, BiPAP, and Sleep Apnea Machines

CPAP (Continuous Positive Airway Pressure) and BiPAP (Bilevel Positive Airway Pressure) machines are the most commonly traveled-with medical devices that create checkpoint complexity. The rules governing them are clear and favorable to the passenger.

Under 14 CFR Part 382, CPAP and BiPAP machines are classified as portable medical devices and never count toward a passenger's carry-on baggage allowance. A passenger traveling with a CPAP machine may bring it in addition to a standard carry-on bag and a personal item. This applies on all U.S. carriers and all foreign carriers operating U.S. routes. Airlines that attempt to count a CPAP machine as a carry-on are violating Part 382 and face per-violation penalty exposure.

At the checkpoint, CPAP machines must be removed from their case and placed in a separate X-ray bin for screening, similar to laptops. Some CPAP machines contain water in the humidifier reservoir; TSA requires the water to be emptied before the machine goes through the X-ray. Traveling with a dedicated X-ray-friendly travel bag for the CPAP, designed with a clear-bottom design that allows the machine to be screened without removal, can speed up the process.

The CPAP battery is subject to the same FAA lithium-ion thresholds that govern all cabin batteries. Batteries under 100 watt-hours require no pre-approval and can travel freely in the cabin. Batteries rated between 101 and 160 watt-hours require advance written approval from the airline, which must be obtained at least 24 hours before travel. Batteries rated over 160 watt-hours are prohibited from the aircraft entirely, regardless of medical necessity. For passengers whose CPAP machine requires a battery above 160Wh, the practical options are using a CPAP model with a lower-wattage battery, using 12V aircraft power if available at the seat, or consulting with the treating physician about alternative devices for travel.

Insulin, Syringes, and Diabetic Equipment

Medical liquids, including insulin, liquid medications, and IV fluids, are exempt from the TSA's standard 3-1-1 liquid rule that limits containers to 3.4 ounces (100 milliliters) each. Medical liquids in any quantity are permitted in carry-on baggage when they are declared to the TSA officer at the beginning of the screening process. Declare your medical liquids proactively and separately from your other carry-on items; do not place them in the standard quart-sized plastic bag with toiletries.

Syringes, lancets, and other diabetic supplies including glucose meters, test strips, and cooling pouches for insulin are all permitted in carry-on baggage. There is no requirement to carry a physician's letter for standard diabetic supplies at U.S. airports, though carrying documentation of your condition can expedite secondary screening if a TSA officer has questions.

For insulin pumps, the TSA and device manufacturers generally advise against passing insulin pumps through millimeter-wave body scanners or X-ray machines, as the radiation exposure may affect device function. Passengers with insulin pumps may request a pat-down instead of scanner screening. This right is specifically protected under Part 382; no TSA officer may require a passenger with an implanted or attached medical device to pass through a scanner if the passenger requests an alternative screening method.

For international travel with insulin, documentation requirements vary significantly by destination. Many countries require a physician's letter on official letterhead, often translated into the local language, confirming the diagnosis and the necessity of the medication. Research destination-specific requirements before travel; the carrier's international travel guide and the destination country's customs authority website are the authoritative sources.

Pacemakers, Cochlear Implants, and Implanted Devices

TSA millimeter-wave body scanners use non-ionizing radiation at frequencies that do not affect the function of pacemakers, cochlear implants, or most other implanted medical devices. The metal detector technology used in older scanner lanes generates a magnetic field that can, in rare cases, interact with certain older pacemaker models. The standard protocol is to inform the TSA officer of any implanted device before entering the scanner and to present the device's implant card if available. The implant card, typically a credit-card-sized document issued by the device manufacturer, specifies the model and any relevant screening considerations.

Passengers with implanted devices who prefer not to pass through any scanner technology may request a physical pat-down in lieu of electronic screening. This right is protected under Part 382. For passengers with cochlear implants, the processor unit worn externally should be removed and placed in a tray before screening, as it is not implanted and can safely pass through the X-ray. The implanted portion does not require any special handling.

At international airports, particularly those in developing markets that use older walk-through metal detector technology rather than millimeter-wave scanners, inform the security officer of any implanted device before entering the metal detector lane. The officer may direct you to an alternative screening method or manually clear you with a handheld wand.

Prescription Medications and Destination Legality

Carrying prescription medications in their original pharmacy-labeled containers is the TSA baseline recommendation for domestic U.S. travel. Medications do not need to be in their original containers under TSA rules, but original containers reduce the likelihood of questions or secondary screening.

The far more consequential issue for international travelers is destination legality. A significant number of medications prescribed and dispensed legally in the United States are classified as controlled substances, prohibited substances, or require specific import documentation in other countries. Travelers who carry these medications without appropriate documentation face consequences ranging from confiscation to arrest and detention.

Japan is one of the most restrictive markets: the Narcotics and Psychotropics Control Law classifies amphetamine-based ADHD medications (Adderall, Vyvanse) and certain combination cold medications containing pseudoephedrine as controlled substances requiring a specific import certificate (yunyu kakuninsho) obtained before travel. Carrying these medications without the certificate, even in the original pharmacy bottle with a valid prescription label, has resulted in arrest and detention at Japanese customs.

The United Arab Emirates similarly restricts a range of medications common in U.S. prescriptions, including opioid-based pain medications, certain antidepressants, and sleep medications. Travelers to the UAE should verify every prescription against the UAE's Ministry of Health approved medications list before travel.

For any international itinerary, verify the controlled substance classification of all prescription medications at every destination and transit country on the route. The U.S. Embassy or Consulate website for the destination country and the destination country's official health ministry are the authoritative sources. A physician's letter and a translated copy of the prescription are minimum documentation for any trip where a medication's legal status is uncertain.

Portable Oxygen Concentrators

Airlines do not supply supplemental oxygen to passengers on demand. Passengers who require supplemental oxygen during flight must use a Portable Oxygen Concentrator (POC) that is specifically approved by the FAA for in-flight use. The FAA maintains a list of approved POC models; using a model not on the FAA approved list will result in denied use of the device during flight and may result in denied boarding.

Advance airline notification is required for POC travel: contact the airline at least 48 to 72 hours before departure, depending on the carrier, to confirm the device model, battery capacity, and any in-flight power requirements. Airlines verify the device against the FAA approved list and confirm that the aircraft's seats include an accessible power outlet if the device requires it. Showing up at the gate without having completed this notification process risks denied boarding.

POC batteries, like all lithium batteries, must travel in carry-on and are subject to the FAA's watt-hour thresholds. Most POC batteries fall in the 100Wh to 160Wh range, which requires carrier approval as part of the advance notification process. Carry enough charged spare batteries for 150% of the expected flight time, per FAA guidance for POC travelers, to account for delays and extended air time.